Diisopropylethylamine → HCID 71576581, 화합물
반응식
[Cl:1][C:2]1[CH:3]=[C:4]([C:9]2([C:26]([F:29])([F:28])[F:27])[O:13][N:12]=[C:11]([C:14]3[N:15]4[C:19]([C:20]([C:23]([OH:25])=O)=[CH:21][CH:22]=3)=[CH:18][CH:17]=[CH:16]4)[CH2:10]2)[CH:5]=[C:6]([Cl:8])[CH:7]=1.CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.Cl.[NH2:64][CH2:65][C:66]1[CH:67]=[CH:68][C:69]2[C:73]([CH2:76][CH3:77])([CH2:74][CH3:75])[O:72][B:71]([OH:78])[C:70]=2[CH:79]=1>CN(C=O)C>[Cl:1][C:2]1[CH:3]=[C:4]([C:9]2([C:26]([F:28])([F:27])[F:29])[O:13][N:12]=[C:11]([C:14]3[N:15]4[C:19]([C:20]([C:23]([NH:64][CH2:65][C:66]5[CH:67]=[CH:68][C:69]6[C:73]([CH2:74][CH3:75])([CH2:76][CH3:77])[O:72][B:71]([OH:78])[C:70]=6[CH:79]=5)=[O:25])=[CH:21][CH:22]=3)=[CH:18][CH:17]=[CH:16]4)[CH2:10]2)[CH:5]=[C:6]([Cl:8])[CH:7]=1참가 물질
6
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
A solution of 5-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)indolizine-8-carboxylic acid (0.24 mmol) and DIPEA (151 mg, 1.17 mmol) in DMF (5.0 mL) can be stirred at rt for 5 min and then HATU (180 mg, 0.47 mmol) was added. The mixture can be stirred for 10 min prior to the addition of 6-(aminomethyl)-3,3-diethylbenzo[c][1,2]oxaborol-1(3H)-ol hydrochloride (63 mg, 0.25 mmol). And the resulting mixture can be stirred at rt overnight. It can be then concentrated under vacuum, and the residue can be partitioned between 1N HCl and ethyl acetate. The organic layer separated can be concentrated under vacuum, and the residue can be purified by column chromatography and prep-HPLC to provide the final title compound.
후처리
- stirringAnd the resulting mixture can be stirred at rt overnight
- concentrationIt can be then concentrated under vacuum
- customthe residue can be partitioned between 1N HCl and ethyl acetate
- customThe organic layer separated can
- concentrationbe concentrated under vacuum
- customthe residue can be purified by column chromatography
출처 및 근거
- ORD 기록
- ord-7a43fc04e57b44559e5c50c6b7cd665b
- 출처 데이터셋
- uspto-grants-2013_10
- 특허 번호
- US08546357B2
반응 노트
불러오는 중…